In 354 patients after pancreatic head resection, adding fluoropyrimidine chemoradiotherapy to adjuvant gemcitabine did not improve overall survival (median 2.3 v 2.6 years; HR 0.96). Grade 3 toxicity rose (38% v 19%).
RCTn = 354
Abrams et al. Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848